Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicomp gets US nod for ambulatory heart monitor:

This article was originally published in Clinica

Executive Summary

United Therapeutics subsidiary Medicomp has received US FDA approval to market what it claims is the first ambulatory heart monitor to detect the p-wave, a diminutive but critical portion of an ECG that represents atrial activity. The CardioPAL SAVI monitor uses artificial intelligence to continually assess the heart, capturing ECG data from symptomatic patients while automatically recording asymptomatic ECG irregularities based on unusual rates, rhythms, or morphologies (waveform shapes). In addition, the system uses the Diogenes SV algorithm to perform real-time supraventricular analysis, said Melbourne, Florida-based Medicomp.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT055104

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel